NEWTON, Mass., Nov. 26, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers for the ...
Marinomed Biotech AG signs agreement for sale of Carragelose business to French Unither Pharmaceuticals. Marinomed to sell Carragelose business to Unither Pharmaceuticals, a leadi ...